sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Varicella Virus Vaccine

Varicella Virus Vaccine Market By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and Others), and By Distribution Channel (Hospital, Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Jun-2020
  • Total Pages: 189
  • Report Code: FAF-1187
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Varicella virus vaccine industry. The report analyzes and declares the historical and current trends analysis of the Varicella virus vaccine industry and subsequently recommends the projected trends anticipated to be observed in the Varicella virus vaccine market during the upcoming years.

The Varicella virus vaccine market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Varicella virus vaccine market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Varicella virus vaccine industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Varicella virus vaccine industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Varicella virus vaccine market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Varicella virus vaccine industry. The Varicella virus vaccine market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Varicella virus vaccine sector. Key strategic developments in the Varicella virus vaccine market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Varicella virus vaccine market are appropriately highlighted in the report.

The Varicella virus vaccine market research report delivers an acute valuation and taxonomy of the Varicella virus vaccine industry by practically splitting the market on the basis of different types, category and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Varicella virus vaccine industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Varicella virus vaccine industry is provided for the leading economies of the world.

Varicella virus vaccine market was accounted for approximately USD 711 Million in 2019. The market is expected to grow above a CAGR of 4.8% and is anticipated to reach over USD 1,020 Million by 2026.

The main drivers of growing growth across the world market for live vaccines for varicella are increased awareness of the use of live vaccines for varicella and increased recognition of live vaccines for varicella. Successful policy policies and ongoing immunization measures would fuel the development of live vaccines for varicella on both markets. Recent developments in the acceptance of live vaccines for varicella have taken place around the world. That's because of the common, simple availability of these vaccines.

Improved immunization campaigns worldwide, increased awareness of the use of live vaccines for varicella, and increased acceptance of live vaccines for varicella are key factors in increasing global demand for live varicella. High government inputs aligned with output, on either side, somehow constrains growth. However, strong growth opportunities within developing economies have laid the foundation for a variety of opportunities within the industry.

The Varicella virus vaccine market is segmented based on drug class, distribution channel and region. On the basis of drug class segmentation, the market is classified into Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and others. Based on distribution channel, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel

Some of the essential players operating in the Varicella virus vaccine market, but not restricted to include GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Merck KGaA, Alvizia Health Care, Novartis AG, Bayer AG, Roche Incand Others.

The taxonomy of the Varicella virus vaccine industry by its scope and segmentation is as follows:

Global Varicella virus vaccine Market: By Drug Class Segmentation Analysis

  • Quinine
  • Chloroquine
  • Proguanil
  • Mefloquine
  • Pyrimethamine
  • Others

Global Varicella virus vaccine Market: By Distribution Channel Segmentation Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
  • Other Distribution Channel

Global Varicella virus vaccine Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Varicella virus vaccine market – Drug Class Analysis
    1. 2.1. Global Varicella virus vaccine Market – Drug Class Overview
    2. 2.2. Global Varicella virus vaccine Market Share, by Drug Class, 2019 & 2026 (USD Million)
    3. 2.3. Quinine
      1. 2.3.1. Global Quinine Varicella virus vaccine Market, 2016-2026 (USD Million)
    4. 2.4. Chloroquine
      1. 2.4.1. Global Chloroquine Varicella virus vaccine Market, 2016-2026 (USD Million)
    5. 2.5. Proguanil
      1. 2.5.1. Global Proguanil Varicella virus vaccine Market, 2016-2026 (USD Million)
    6. 2.6. Mefloquine
      1. 2.6.1. Global Mefloquine Varicella virus vaccine Market, 2016-2026 (USD Million)
    7. 2.7. Pyrimethamine
      1. 2.7.1. Global Pyrimethamine Varicella virus vaccine Market, 2016-2026 (USD Million)
    8. 2.8. Others
      1. 2.8.1. Global Others Varicella virus vaccine Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Varicella virus vaccine market – Distribution Channel Analysis
    1. 3.1. Global Varicella virus vaccine Market – Distribution Channel Overview
    2. 3.2. Global Varicella virus vaccine Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
    3. 3.3. Hospital Pharmacy
      1. 3.3.1. Global Hospital Pharmacy Varicella virus vaccine Market, 2016-2026 (USD Million)
    4. 3.4. Retail Pharmacy
      1. 3.4.1. Global Retail Pharmacy Varicella virus vaccine Market, 2016-2026 (USD Million)
    5. 3.5. E-Commerce
      1. 3.5.1. Global E-Commerce Varicella virus vaccine Market, 2016-2026 (USD Million)
    6. 3.6. Other Distribution Channel
      1. 3.6.1. Global Other Distribution Channel Varicella virus vaccine Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Varicella virus vaccine market – Regional Analysis
    1. 4.1. Global Varicella virus vaccine Market Regional Overview
    2. 4.2. Global Varicella virus vaccine Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Varicella virus vaccine Market size and forecast, 2016-2026
      2. 4.3.2. North America Varicella virus vaccine Market, by Country, 2019 & 2026 (USD Million)
      3. 4.3.3. North America Varicella virus vaccine Market, by Drug Class, 2016-2026
        1. 4.3.3.1. North America Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.3.4. North America Varicella virus vaccine Market, by Distribution Channel, 2016-2026
        1. 4.3.4.1. North America Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe Varicella virus vaccine Market size and forecast, 2016-2026
      2. 4.4.2. Europe Varicella virus vaccine Market, by Country, 2019 & 2026 (USD Million)
      3. 4.4.3. Europe Varicella virus vaccine Market, by Drug Class, 2016-2026
        1. 4.4.3.1. Europe Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.4.4. Europe Varicella virus vaccine Market, by Distribution Channel, 2016-2026
        1. 4.4.4.1. Europe Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Varicella virus vaccine Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Varicella virus vaccine Market, by Country, 2019 & 2026 (USD Million)
      3. 4.5.3. Asia Pacific Varicella virus vaccine Market, by Drug Class, 2016-2026
        1. 4.5.3.1. Asia Pacific Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.5.4. Asia Pacific Varicella virus vaccine Market, by Distribution Channel, 2016-2026
        1. 4.5.4.1. Asia Pacific Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Varicella virus vaccine Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Varicella virus vaccine Market, by Country, 2019 & 2026 (USD Million)
      3. 4.6.3. Latin America Varicella virus vaccine Market, by Drug Class, 2016-2026
        1. 4.6.3.1. Latin America Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.6.4. Latin America Varicella virus vaccine Market, by Distribution Channel, 2016-2026
        1. 4.6.4.1. Latin America Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Varicella virus vaccine Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Varicella virus vaccine Market, by Country, 2019 & 2026 (USD Million)
      3. 4.7.3. The Middle-East and Africa Varicella virus vaccine Market, by Drug Class, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
      4. 4.7.4. The Middle-East and Africa Varicella virus vaccine Market, by Distribution Channel, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. Varicella virus vaccine market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. GlaxoSmithKline Plc.
      1. 6.1.1. Company Overview
      2. 6.1.2. GlaxoSmithKline Plc. Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Pfizer
      1. 6.2.1. Company Overview
      2. 6.2.2. Pfizer Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Ranbaxy Laboratories
      1. 6.3.1. Company Overview
      2. 6.3.2. Ranbaxy Laboratories Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Zydus Cadila
      1. 6.4.1. Company Overview
      2. 6.4.2. Zydus Cadila Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Ipca Laboratories Ltd.
      1. 6.5.1. Company Overview
      2. 6.5.2. Ipca Laboratories Ltd. Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Merck KGaA
      1. 6.6.1. Company Overview
      2. 6.6.2. Merck KGaA Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Alvizia Health Care
      1. 6.7.1. Company Overview
      2. 6.7.2. Alvizia Health Care Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Novartis AG
      1. 6.8.1. Company Overview
      2. 6.8.2. Novartis AG Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Bayer AG
      1. 6.9.1. Company Overview
      2. 6.9.2. Bayer AG Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Roche Inc.
      1. 6.10.1. Company Overview
      2. 6.10.2. Roche Inc. Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Varicella virus vaccine — Industry Analysis
    1. 7.1. Varicella virus vaccine Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Varicella virus vaccine Market – Attractiveness Analysis
      1. 7.4.1. By Drug Class
      2. 7.4.2. By Distribution Channel
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 2 Global Varicella virus vaccine Market Share, by Drug Class, 2019 & 2026 (USD Million)
        FIG. 3 Global Quinine Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 4 Global Chloroquine Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 5 Global Proguanil Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 6 Global Mefloquine Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 7 Global Pyrimethamine Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 8 Global Others Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 9 Global Varicella virus vaccine Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
        FIG. 10 Global Hospital Pharmacy Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 11 Global Retail Pharmacy Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 12 Global E-Commerce Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 13 Global Other Distribution Channel Varicella virus vaccine Market, 2016-2026 (USD Million)
        FIG. 14 Global Varicella virus vaccine Market Share, by Region, 2019 & 2026
        FIG. 15 North America Varicella virus vaccine Market, 2016-2026
        FIG. 16 U.S. Varicella virus vaccine Market, 2016-2026
        FIG. 17 Canada Varicella virus vaccine Market, 2016-2026
        FIG. 18 Europe Varicella virus vaccine Market, 2016-2026
        FIG. 19 Germany Varicella virus vaccine Market, 2016-2026
        FIG. 20 France Varicella virus vaccine Market, 2016-2026
        FIG. 21 U.K. Varicella virus vaccine Market, 2016-2026
        FIG. 22 Italy Varicella virus vaccine Market, 2016-2026
        FIG. 23 Spain Varicella virus vaccine Market, 2016-2026
        FIG. 24 Rest of Europe Varicella virus vaccine Market, 2016-2026
        FIG. 25 Asia Pacific Varicella virus vaccine Market, 2016-2026
        FIG. 26 China Varicella virus vaccine Market, 2016-2026
        FIG. 27 Japan Varicella virus vaccine Market, 2016-2026
        FIG. 28 India Varicella virus vaccine Market, 2016-2026
        FIG. 29 South  Korea Varicella virus vaccine Market, 2016-2026
        FIG. 30 South-East Asia Varicella virus vaccine Market, 2016-2026
        FIG. 31 Rest of Asia Pacific Varicella virus vaccine Market, 2016-2026
        FIG. 32 Latin America Varicella virus vaccine Market, 2016-2026
        FIG. 33 Brazil Varicella virus vaccine Market, 2016-2026
        FIG. 34 Mexico Varicella virus vaccine Market, 2016-2026
        FIG. 35 Rest of Latin America Varicella virus vaccine Market, 2016-2026
        FIG. 36 The Middle-East and Africa Varicella virus vaccine Market, 2016-2026
        FIG. 37 GCC Countries Varicella virus vaccine Market, 2016-2026
        FIG. 38 South Africa Varicella virus vaccine Market, 2016-2026
        FIG. 39 Rest of Middle-East Africa Varicella virus vaccine Market, 2016-2026
        FIG. 40 Competitor Market Share – Revenue
        FIG. 41 GlaxoSmithKline Plc. Revenue and Growth Rate
        FIG. 42 GlaxoSmithKline Plc. Market Share
        FIG. 43 Pfizer Revenue and Growth Rate
        FIG. 44 Pfizer Market Share
        FIG. 45 Ranbaxy Laboratories Revenue and Growth Rate
        FIG. 46 Ranbaxy Laboratories Market Share
        FIG. 47 Zydus Cadila Revenue and Growth Rate
        FIG. 48 Zydus Cadila Market Share
        FIG. 49 Ipca Laboratories Ltd. Revenue and Growth Rate
        FIG. 50 Ipca Laboratories Ltd. Market Share
        FIG. 51 Merck KGaA Revenue and Growth Rate
        FIG. 52 Merck KGaA Market Share
        FIG. 53 Alvizia Health Care Revenue and Growth Rate
        FIG. 54 Alvizia Health Care Market Share
        FIG. 55 Novartis AG Revenue and Growth Rate
        FIG. 56 Novartis AG Market Share
        FIG. 57 Bayer AG Revenue and Growth Rate
        FIG. 58 Bayer AG Market Share
        FIG. 59 Roche Inc. Revenue and Growth Rate
        FIG. 60 Roche Inc. Market Share
        FIG. 61 Market Dynamics
        FIG. 62 Global Varicella virus vaccine – Value Chain Analysis
        FIG. 63 Technology Roadmap and Timeline
        FIG. 64 Market Attractiveness Analysis – By Drug Class
        FIG. 65 Market Attractiveness Analysis – By Distribution Channel
        FIG. 66 Market Attractiveness Analysis – By Region
        FIG. 67 Market Channel
        FIG. 68 Marketing Channel Development Trend
        FIG. 69 Growth in World Gross Product, 2008-2019

        List of Tables

        TABLE 1 Global Varicella virus vaccine Market, 2019 & 2026 (USD Million)
        TABLE 2 Global Varicella virus vaccine market, by Drug Class, 2016-2026 (USD Million)
        TABLE 3 Global Varicella virus vaccine market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 4 Global Varicella virus vaccine market, by Region, 2016-2026 (USD Million)
        TABLE 5 North America Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 6 North America Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 7 Europe Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 8 Europe Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 9 Asia Pacific Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 10 Asia Pacific Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 11 Latin America Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 12 Latin America Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 13 The Middle-East and Africa Varicella virus vaccine Market, by Drug Class, 2016-2026 (USD Million)
        TABLE 14 The Middle-East and Africa Varicella virus vaccine Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 15 Global Varicella virus vaccine Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 16 Global Varicella virus vaccine Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • According to the primary CXO’s of the global Varicella virus vaccine market, the market is estimated to witness a substantial growth of nearly 4.8% over the forecast period.
  • The market was valued at USD 711 million, in 2019 and is expected to be valued over USD 1,020 million.
  • On the basis of the drug class segment, Chloroquine dominated the global Varicella virus vaccine market in 2019. In terms of revenue, it accounted for more than a 27% share of the total market in 2019.
  • Asia Pacific market is expected to be the fastest goring region for Varicella virus vaccine over the forecast period owing to growing investments for R&D and pharmaceuticals companies in the region.
  • By geography, the North America region headed the market with a share of above 33%, in 2019.

Key Recommendations from Analysts

  • Higher prevalence of malaria cases, technological advances, high unmet medical needs and government initiatives are major factors that are expected to drive the development of the treatment market for malaria in the near future.
  • The strategic developments such as regional expansion, product innovations and on-going research and developments by the major companies such as G GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, etc. is likely to boom the market’s growth over the up-coming years.
  • Our analysts recommend that the Asia Pacific region is predicted to witness a significant growth attributed to the growing demand for Varicella virus vaccine from China and India.   
  • Expansion of pharmaceuticals companies especially in emerging market is antipicated to fuel the demand for Varicella virus vaccine drug in the developing regions over the forthcoming years.
  • Strengthening the distribution channel and growing availability of bipolar disorder drugs online may also help the major player to cater the lucrative growth of the market over the years to come.

Market Share Analysis by Region

Industry Major Market Players

  • GlaxoSmithKline Plc.
  • Pfizer
  • Ranbaxy Laboratories
  • Zydus Cadila
  • Ipca Laboratories Ltd.
  • Merck KGaA
  • Alvizia Health Care
  • Novartis AG
  • Bayer AG
  • Roche Incand

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions